EOAI3402143 is primarily utilized in the field of medicinal chemistry, where it serves as a potent inhibitor targeting specific enzymes involved in disease pathways. Its application is particularly significant in cancer research, as it effectively disrupts the activity of proteins that contribute to tumor growth and survival. This compound is also explored in preclinical studies for its potential to enhance the efficacy of existing therapeutic agents when used in combination treatments. Additionally, EOAI3402143 is investigated for its role in modulating cellular processes, offering insights into novel drug development strategies for various pathological conditions.